Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.

about

Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.

Item

http://www.wikidata.org/entity/Q50897221

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@en

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@nl

type

Item

label

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@en

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@nl

prefLabel

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@en

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@nl

P1476

Small molecule inhibitor TW-37 ...... y in nasopharyngeal carcinoma.

@en

P2093

Dagui Chen

http://www.w3.org/2001/XMLSchema#string

Haixin Huang

http://www.w3.org/2001/XMLSchema#string

Hui Yang

http://www.w3.org/2001/XMLSchema#string

Rensheng Wang

http://www.w3.org/2001/XMLSchema#string

Sibei Wu

http://www.w3.org/2001/XMLSchema#string

Ying Lu

http://www.w3.org/2001/XMLSchema#string

Zhou Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting BCL2-Proteins for the Treatment of Solid Tumours

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

ONCOMINE: a cancer microarray database and integrated data-mining platform

Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.

Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation

B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.

Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells.

A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.

P304

1376-1383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384101.2017.1329066

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696828

http://www.w3.org/2001/XMLSchema#string

P932

5539829

http://www.w3.org/2001/XMLSchema#string